Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer
Background Factor (F) V is an essential cofactor in blood coagulation, however, F5 expression in breast tumors has also been linked to tumor aggressiveness and overall survival. The specific role of FV in breast cancer is yet unknown. We therefore aimed at dissecting the biological relevance of FV i...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2020.1824644 |
id |
doaj-11852d9b136846c3ae75838cff175194 |
---|---|
record_format |
Article |
spelling |
doaj-11852d9b136846c3ae75838cff1751942021-09-24T14:41:25ZengTaylor & Francis GroupOncoImmunology2162-402X2020-01-019110.1080/2162402X.2020.18246441824644Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancerMari Tinholt0Benedicte Stavik1Xavier Tekpli2Øystein Garred3Elin Borgen4Vessela Kristensen5Kristine Kleivi Sahlberg6Per Morten Sandset7Nina Iversen8Oslo University HospitalOslo University HospitalOslo University HospitalOslo University HospitalOslo University HospitalOslo University HospitalInstitute for Cancer Research, Oslo University Hospital RadiumhospitaletOslo University HospitalOslo University HospitalBackground Factor (F) V is an essential cofactor in blood coagulation, however, F5 expression in breast tumors has also been linked to tumor aggressiveness and overall survival. The specific role of FV in breast cancer is yet unknown. We therefore aimed at dissecting the biological relevance of FV in breast cancer. Methods Gene expression data from a Scandinavian breast cancer cohort (n = 363) and the cancer genome atlas (TCGA) (n = 981) and 12 replication cohorts were used to search for F5 co-expressed genes, followed by gene ontology analysis. Pathological and bioinformatic tools were used to evaluate immune cell infiltration and tumor purity. T cell activation, proliferation and migration were studied in FV treated Jurkat T cells. Results F5 co-expressed genes were mainly associated with immune system processes and cell activation. Tumors with high expression of F5 were more infiltrated with both lymphoid (T cells, NK cells, and B cells) and myeloid cells (macrophages and dendritic cells), and F5 expression was negatively correlated with tumor purity (ρ = −0.32). Confirming a prognostic role, data from the Kaplan-Meier plotter showed that high F5 expression was associated with improved relapse-free survival. The strongest association was observed in basal-like breast cancer (HR = 0.55; 95% CI, 0.42–0.71). Exogenous FV did not substantially affect activation, proliferation or migration of human T cells. Conclusions F5 was identified as a novel marker of immune cell infiltration in breast cancer, and the prognostic role of F5 was verified. FV emerge as an interesting immunological biomarker with potential therapeutic relevance for the cancer-inflammation-thrombosis circuit.http://dx.doi.org/10.1080/2162402X.2020.1824644blood coagulationfactor vbreast neoplasmsurvivalcellular immune response |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mari Tinholt Benedicte Stavik Xavier Tekpli Øystein Garred Elin Borgen Vessela Kristensen Kristine Kleivi Sahlberg Per Morten Sandset Nina Iversen |
spellingShingle |
Mari Tinholt Benedicte Stavik Xavier Tekpli Øystein Garred Elin Borgen Vessela Kristensen Kristine Kleivi Sahlberg Per Morten Sandset Nina Iversen Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer OncoImmunology blood coagulation factor v breast neoplasm survival cellular immune response |
author_facet |
Mari Tinholt Benedicte Stavik Xavier Tekpli Øystein Garred Elin Borgen Vessela Kristensen Kristine Kleivi Sahlberg Per Morten Sandset Nina Iversen |
author_sort |
Mari Tinholt |
title |
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer |
title_short |
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer |
title_full |
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer |
title_fullStr |
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer |
title_full_unstemmed |
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer |
title_sort |
coagulation factor v is a marker of tumor-infiltrating immune cells in breast cancer |
publisher |
Taylor & Francis Group |
series |
OncoImmunology |
issn |
2162-402X |
publishDate |
2020-01-01 |
description |
Background Factor (F) V is an essential cofactor in blood coagulation, however, F5 expression in breast tumors has also been linked to tumor aggressiveness and overall survival. The specific role of FV in breast cancer is yet unknown. We therefore aimed at dissecting the biological relevance of FV in breast cancer. Methods Gene expression data from a Scandinavian breast cancer cohort (n = 363) and the cancer genome atlas (TCGA) (n = 981) and 12 replication cohorts were used to search for F5 co-expressed genes, followed by gene ontology analysis. Pathological and bioinformatic tools were used to evaluate immune cell infiltration and tumor purity. T cell activation, proliferation and migration were studied in FV treated Jurkat T cells. Results F5 co-expressed genes were mainly associated with immune system processes and cell activation. Tumors with high expression of F5 were more infiltrated with both lymphoid (T cells, NK cells, and B cells) and myeloid cells (macrophages and dendritic cells), and F5 expression was negatively correlated with tumor purity (ρ = −0.32). Confirming a prognostic role, data from the Kaplan-Meier plotter showed that high F5 expression was associated with improved relapse-free survival. The strongest association was observed in basal-like breast cancer (HR = 0.55; 95% CI, 0.42–0.71). Exogenous FV did not substantially affect activation, proliferation or migration of human T cells. Conclusions F5 was identified as a novel marker of immune cell infiltration in breast cancer, and the prognostic role of F5 was verified. FV emerge as an interesting immunological biomarker with potential therapeutic relevance for the cancer-inflammation-thrombosis circuit. |
topic |
blood coagulation factor v breast neoplasm survival cellular immune response |
url |
http://dx.doi.org/10.1080/2162402X.2020.1824644 |
work_keys_str_mv |
AT maritinholt coagulationfactorvisamarkeroftumorinfiltratingimmunecellsinbreastcancer AT benedictestavik coagulationfactorvisamarkeroftumorinfiltratingimmunecellsinbreastcancer AT xaviertekpli coagulationfactorvisamarkeroftumorinfiltratingimmunecellsinbreastcancer AT øysteingarred coagulationfactorvisamarkeroftumorinfiltratingimmunecellsinbreastcancer AT elinborgen coagulationfactorvisamarkeroftumorinfiltratingimmunecellsinbreastcancer AT vesselakristensen coagulationfactorvisamarkeroftumorinfiltratingimmunecellsinbreastcancer AT kristinekleivisahlberg coagulationfactorvisamarkeroftumorinfiltratingimmunecellsinbreastcancer AT permortensandset coagulationfactorvisamarkeroftumorinfiltratingimmunecellsinbreastcancer AT ninaiversen coagulationfactorvisamarkeroftumorinfiltratingimmunecellsinbreastcancer |
_version_ |
1717369720709054464 |